United States· US:33342-117_4079c843-42ee-4f7a-a4a0-9498ba6cf12d
Candesartan
A medicinal product containing candesartan cilexetil, registered in United States by Macleods Pharmaceuticals Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CANDESARTAN CILEXETIL
- Manufacturer
- Macleods Pharmaceuticals Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1133342-117-07
- ndc1133342-117-10
- ndc1133342-117-12
- ndc1133342-117-51
- ndc11333421170730 TABLET in 1 CONTAINER (33342-117-07)
- ndc11333421171090 TABLET in 1 CONTAINER (33342-117-10)
- ndc11333421171210 BLISTER PACK in 1 CARTON (33342-117-12) / 10 TABLET in 1 BLISTER PACK
- ndc113334211751300 TABLET in 1 CONTAINER (33342-117-51)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Candesartan cilexetil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCANOCORDKrka, d.d., Novo mesto, Novo mesto
- FinlandAmiasOrifarm Oy
- ItalyBLOPRESSMEDIFARM S.R.L.
- CanadaACH-CANDESARTANACCORD HEALTHCARE INC
- FranceCANDESARTAN ARROW 32 mg, comprimé sécableARROW GENERIQUES
- SwedenAtacand 32 mg TablettCheplapharm Arzneimittel GmbH
- NorwayAtacandCheplapharm Arzneimittel GmbH
- IrelandBlopress 32 mg TabletsCHEPLAPHARM Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Atacand, Blopress
- Belgium · Atacand, Candesartan Eg
- Bulgaria · Атаканд, Кандекон
- Cyprus · Atacand, Candepress
- Czechia · Canocord, Carzap
- Germany · Atacand, Atacand Protect
- Denmark · Atacand, Candemox
- Estonia · Atacand, Canocord
- Spain · Atacand, Blopress
- Finland · Atacand, Candemox
- France · Atacand, Candesartan Arrow
- United Kingdom (Northern Ireland) · Amias, Atacand
- Greece · Atacand, Fyronexe
- Croatia · Kandepres, Kandepres 16
- Hungary · Karbis
- Ireland · Atacand, Blopress
- Iceland · Candesartan Stada, Candpress
- Italy · Blopress, Candesartan Alter
- Lithuania · Canocord, Carzan
- Luxembourg · Atacand, Candesartan Eg
- Latvia · Canocord, Carzan
- Malta · Candesartan, Candesartan Cilexetil Aurobindo Pharma (Malta)
- Netherlands · Atacand, Candesartan Cilexetil Aurobindo
- Norway · Atacand, Candesartan Krka
- Poland · Atacand, Candepres
- Portugal · Atacand, Blopress
- Romania · Atacand, Candesartan
- Sweden · Atacand, Canderion
- Slovenia · Atacand, Candea
- Slovakia · Atacand, Candesartan Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e23db30b-7d9c-46b7-9b7b-08835ce495f2 GET /v1/drugs/e23db30b-7d9c-46b7-9b7b-08835ce495f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "32",
"substance": "CANDESARTAN CILEXETIL",
"productndc": "33342-117",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA203813",
"marketing_category": "ANDA"
}See everything about candesartan cilexetil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.